B. Lueza

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

Dirk Arnold, B. Lueza, Jean-Yves Douillard et al. · Annals of Oncology · 2017 · 836 citations · Full text

Medicine, Oncology, Pharmacology +15

Extrapolation of Survival Curves from Cancer Trials Using External Information

Patricia Guyot, A. E. Ades, Matthew Beasley et al. · Medical Decision Making · 2016 · 84 citations · Full text

Public Health, Biostatistics, Oncology +17

Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients

Mélinda Charrier, Laura Mezquita, B. Lueza et al. · European Journal of Cancer · 2019 · 47 citations · Full text

Medicine, Immunology, Oncology +12

Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer

Julia Bonastre, Sophie Marguet, B. Lueza et al. · Journal of Clinical Oncology · 2014 · 33 citations

Pharmacy, Oncology, Pharmacoeconomics +17

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non–small-cell Lung Cancer

Lesley Seymour, Gwénaël Le Teuff, Élisabeth Brambilla et al. · Clinical Lung Cancer · 2018 · 24 citations

Medicine, Oncology, Pathology +12